Search


Current filters:






Start a new search
Add filters:

Use filters to refine the search results.


Results 1-5 of 5 (Search time: 0.001 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2008Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotypeEnglish, D.; Young, J.; Simpson, J.; Jenkins, M.; Southey, M.; Walsh, M.; Buchanan, D.; Barker, M.; Haydon, A.; Royce, S.; Roberts, A.; Parry, S.; Hopper, J.; Jass, J.; Giles, G.
2008Association of PARL rs3732581 genetic variant with insulin levels, metabolic syndrome and coronary artery diseasePowell, B.; Wiltshire, S.; Arscott, G.; McCaskie, P.; Hung, J.; McQuillan, B.; Thompson, P.; Carter, K.; Palmer, L.; Beilby, J.
2008Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemiale Coutre, P.; Ottmann, O.; Giles, F.; Kim, D.; Cortes, J.; Gattermann, N.; Apperley, J.; Larson, R.; Abruzzese, E.; O'Brien, S.; Kuliczkowski, K.; Hochhaus, A.; Mahon, F.; Saglio, G.; Gobbi, M.; Kwong, Y.; Baccarani, M.; Hughes, T.; Martinelli, G.; Radich, J.; et al.
2008K-ras mutations and benefit from cetuximab in advanced colorectal cancerKarapetis, C.; Khambata-Ford, S.; Jonker, D.; O'Callaghan, C.; Tu, D.; Tebbutt, N.; Simes, R.; Chalchal, H.; Shapiro, J.; Robitaille, S.; Price, T.; Shepherd, L.; Au, H.; Langer, C.; Moore, M.; Zalcberg, J.
20083D radiotheraphy can be safely combined with sandwich systemic gemcitabine chemotheraphy in the management of pancreatic cancer: factors influencing outcomeSpry, N.; Harvey, J.; MacLeod, C.; Borg, M.; Ngan, S.; Millar, J.; Graham, P.; Zissiadis, Y.; Kneebone, A.; Carroll, S.; Davies, T.; Reece, W.; Iacopetta, B.; Goldstein, D.